In this week's 'What's Hot' Sarah asks how understated the hot pink concept Jaguar is, which hospitality stock isn't budget bashing and what is the future for one Phoenix-rising, business-buying bank.
For the six months ended September 30, the investment trust realised a 1.9% decline in NAV total returns per share, whilst its benchmark, the MSCI world index returned 2.8% over the same period.
(Sharecast News) - London stocks were still in the black by midday on Tuesday as investors mulled the latest UK retail sales data and with easyJet flying high on the back of upbeat broker notes. The ...
(Alliance News) - PRS REIT PLC on Tuesday said it is in active discussions with "a number of interested parties" about a potential sale of the company.
(Alliance News) - The UK chancellor has appointed Tom Hayhoe as Covid corruption commissioner to claw back taxpayers' money wasted on deals during the pandemic. He has started a review of GBP8.7 ...
(Alliance News) - HgCapital Trust PLC on Tuesday confirmed its manager, Hg, has agreed to the sale of bookkeeping platform Dext Software Ltd to IRIS Software Group for an undisclosed sum.
(Alliance News) - On the Beach Group PLC on Tuesday declared a final dividend and launched a GBP25 million share buyback, as cash piled up thanks to a near doubling in annual profit. On the Beach ...
The Uxbridge, England-based construction company said its Building division has won a GBP53 million contract from Cadogan Estates Ltd to redevelop 30-33 Sloane Street in west London. The project will ...
(Alliance News) - The emir of Qatar will begin a two-day state visit to the UK hosted by the King. Charles will welcome Sheikh Tamim bin Hamad Al Thani and the first of his three wives, Sheikha ...
Derwent London PLC on Tuesday announced it has bought the remaining stake in its proposed 50 Baker Street W1 scheme from Lazari Investments Ltd, its joint venture partner. The London-based property ...
Hutchmed China's Elunate formula contains fruquintinib, while Innovent developed the Sintilimab injection with TYVYT. The combined formula has been approved for use in patients with advanced ...